Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02980835 · ClinicalTrials.gov registry record · Phase 4
Optimal Timing of Intercostal Nerve Blocks During Video-Assisted Thoracic Surgeries
A Phase 4 study of Video Assisted Thoracoscopic Surgery and Video-Assisted Thoracic Surgery, sponsored by University at Buffalo.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT02980835: Completed Phase 4 study of Video Assisted Thoracoscopic Surgery and Video-Assisted Thoracic Surgery, sponsored by University at Buffalo.
NCT02980835 is a Phase 4 study of Video Assisted Thoracoscopic Surgery and Video-Assisted Thoracic Surgery that has completed, run by University at Buffalo. The registered enrollment target is 36 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02980835, a Phase 4 study of Video Assisted Thoracoscopic Surgery and Video-Assisted Thoracic Surgery, has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Intercostal nerve block, performed under the guidance of videoscope, is a part of standard anesthesia procedures for patients receiving Video-Assisted Thoracic Surgeries. In this double-blind, prospective, multi-center, randomized, controlled clinical trial the investigators aim to compare preemptive versus post-closure intercostal injection of ropivacaine in controlling post-video-assisted thoracotomy pain.
Primary Outcome
VAS scores at rest will be recorded right after surgery and compared in both groups
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG Epinephrine
- DRUG Normal Saline
- DRUG Ropivacaine
Study Locations (1)
New York
- VA Western New York Healthcare System - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2016-09-28 |
| Est. Completion | 2022-03-30 |
| Phase | Phase 4 |
What the finished NCT02980835 record still lists
NCT02980835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Video Assisted Thoracoscopic Surgery appearing as the primary indexed condition, and to 4 interventions - of which Dexamethasone is the first listed.
NCT02980835 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02980835 about?
NCT02980835 is a clinical study titled "Optimal Timing of Intercostal Nerve Blocks During Video-Assisted Thoracic Surgeries". Intercostal nerve block, performed under the guidance of videoscope, is a part of standard anesthesia procedures for patients receiving Video-Assisted Thoracic Surgeries. In this double-blind, prospective, multi-center, randomized, controlled clinical trial the investigators aim to compare preemptiv...
What is the current status of trial NCT02980835?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2016-09-28. Estimated completion is 2022-03-30.
What conditions does trial NCT02980835 study?
This clinical trial studies the following conditions: Video Assisted Thoracoscopic Surgery, Video-Assisted Thoracic Surgery.
What interventions are being tested in trial NCT02980835?
The interventions under investigation include: Dexamethasone (DRUG), Epinephrine (DRUG), Normal Saline (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT02980835?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02980835 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Video Assisted Thoracoscopic Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02980835's enrollment target sits among peer trials
36 1490th of 2000 higher than 495 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI